GlassScriptPhysician profile
Nanako Broughton
NPI 1386710184
$2,879.10
in general payments reported to CMS, 2019-2025
19 companies · $54.78 in 2025
The $54.78 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.31 · 2020: $398 · 2021: $1,671 · 2022: $255 · 2023: $246 · 2024: $207 · 2025: $54.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $1,426.84 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $317.17 | 2020-2023 | Jardiance, Tradjenta |
| Lilly USA, LLC | $254.23 | 2020-2022 | |
| Edwards Lifesciences Corporation | $206.79 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Glaxosmithkline, LLC. | $134.69 | 2020-2022 | |
| Novo Nordisk INC | $123.71 | 2021-2023 | |
| Astrazeneca Pharmaceuticals LP | $66.19 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $47.31 | 2019 | |
| Boston Scientific Corporation | $45.09 | 2023 | Superion Indirect Decompression System |
| Inspire Medical Systems, INC. | $40.60 | 2025 | Inspire |
| Sanofi-Aventis U.S. LLC | $37.11 | 2020-2022 | |
| Pfizer INC. | $34.60 | 2022-2023 | |
| Sanofi Pasteur INC. | $32.18 | 2021 | |
| Becton, Dickinson and Company | $31.99 | 2022-2025 | Bd Onclarity |
| Amarin Pharma, INC. | $21.03 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $15.80 | 2021 | |
| Cranial Technologies, INC | $15.73 | 2020 | |
| Abbvie INC. | $14.52 | 2021 | |
| Currax Pharmaceuticals LLC | $13.52 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nanako Broughton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.